Izurieta HS - Search Results

1

Kochhar S, Izurieta HS, Chandler RE, Hacker A, Chen RT, Levitan B. Kochhar S, et al. Among authors: izurieta hs. Vaccine. 2024 Feb 6;42(4):969-971. doi: 10.1016/j.vaccine.2023.07.041. Epub 2023 Aug 8. Vaccine. 2024. PMID: 37563049 Free article.

2

Anosmia: Brighton Collaboration case definition and guidelines for data collection, analysis, and presentation of immunization safety data.

Liu YC, Munoz FM, Izurieta HS, Tamborska AA, Solomon T, Law BJ, Chhabra N. Liu YC, et al. Among authors: izurieta hs. Vaccine. 2023 Mar 10;41(11):1902-1910. doi: 10.1016/j.vaccine.2022.11.022. Epub 2023 Feb 10. Vaccine. 2023. PMID: 36775774 Free article. Review.

3

Real-world Effectiveness of mRNA COVID-19 Vaccines Among US Nursing Home Residents Aged ≥65 Years in the Pre-Delta and High Delta Periods.

Lu Y, Lindaas A, Matuska K, Izurieta HS, McEvoy R, Menis M, Shi X, Steele WR, Wernecke M, Chillarige Y, Wong HL, Kelman JA, Forshee RA. Lu Y, et al. Among authors: izurieta hs. Open Forum Infect Dis. 2024 Jan 29;11(3):ofae051. doi: 10.1093/ofid/ofae051. eCollection 2024 Mar. Open Forum Infect Dis. 2024. PMID: 38505296 Free PMC article.

4

Autoimmune hepatitis: Brighton Collaboration case definition and guidelines for data collection, analysis, and presentation of immunisation safety data.

Kochhar S, Assis DN, Mack C, Izurieta HS, Muratori L, Munoz A, Nordenberg D, Gidudu JF, Blau EF, Vierling JM. Kochhar S, et al. Among authors: izurieta hs. Vaccine. 2024 Mar 7;42(7):1812-1825. doi: 10.1016/j.vaccine.2024.01.021. Epub 2024 Feb 16. Vaccine. 2024. PMID: 38368225 Free article. Review.

5

The role of real-world evidence for regulatory and public health decision-making for Accelerated Vaccine Deployment- a meeting report.

Bollaerts K, Wyndham-Thomas C, Miller E, Izurieta HS, Black S, Andrews N, Rubbrecht M, Van Heuverswyn F, Neels P. Bollaerts K, et al. Among authors: izurieta hs. Biologicals. 2024 Feb;85:101750. doi: 10.1016/j.biologicals.2024.101750. Epub 2024 Feb 15. Biologicals. 2024. PMID: 38360428 Free article.

6

The Brighton collaboration standardized module for vaccine benefit-risk assessment.

Levitan B, Hadler SC, Hurst W, Izurieta HS, Smith ER, Baker NL, Bauchau V, Chandler R, Chen RT, Craig D, King J, Pitisuttithum P, Strauss W, Tomczyk S, Zafack J, Kochhar S. Levitan B, et al. Among authors: izurieta hs. Vaccine. 2024 Feb 6;42(4):972-986. doi: 10.1016/j.vaccine.2023.09.039. Epub 2023 Dec 21. Vaccine. 2024. PMID: 38135642 Free article.

7

Risk of Severe COVID-19 in Prevalent Users of Alpha-1 Adrenergic Receptor Antagonists: A National Case-Control Study of Medicare Beneficiaries.

Graham DJ, Izurieta HS, Zhang D, Avagyan A, Lyu H, Wiederhorn R, Lu Y, Mosholder AD, Smith ER, Zhao Y, Shangguan S, Tsai HT, Pennap D, Sandhu AT, Wernecke M, MaCurdy TE, Kelman JA, Forshee RA. Graham DJ, et al. Among authors: izurieta hs. Am J Med. 2023 Oct;136(10):1018-1025.e3. doi: 10.1016/j.amjmed.2023.07.003. Epub 2023 Jul 15. Am J Med. 2023. PMID: 37454868

8

Effectiveness of mRNA COVID-19 vaccines against Omicron and Delta variants in a matched test-negative case-control study among US veterans.

Young-Xu Y, Zwain GM, Izurieta HS, Korves C, Powell EI, Smith J, Balajee A, Holodniy M, Beenhouwer DO, Rodriguez-Barradas MC, Brown ST, Marconi VC. Young-Xu Y, et al. Among authors: izurieta hs. BMJ Open. 2022 Aug 3;12(8):e063935. doi: 10.1136/bmjopen-2022-063935. BMJ Open. 2022. PMID: 35922100 Free PMC article.

9

Relative effectiveness of booster vs. 2-dose mRNA Covid-19 vaccination in the Veterans Health Administration: Self-controlled risk interval analysis.

Korves C, Izurieta HS, Smith J, Zwain GM, Powell EI, Balajee A, Ryder KM, Young-Xu Y. Korves C, et al. Among authors: izurieta hs. Vaccine. 2022 Aug 5;40(33):4742-4747. doi: 10.1016/j.vaccine.2022.06.047. Epub 2022 Jun 21. Vaccine. 2022. PMID: 35773122 Free PMC article.

10

Risk Factors for COVID-19 Deaths Among Elderly Nursing Home Medicare Beneficiaries in the Prevaccine Period.

Lu Y, Jiao Y, Graham DJ, Wu Y, Wang J, Menis M, Chillarige Y, Wernecke M, Kelman J, Forshee RA, Izurieta HS. Lu Y, et al. Among authors: izurieta hs. J Infect Dis. 2022 Feb 15;225(4):567-577. doi: 10.1093/infdis/jiab515. J Infect Dis. 2022. PMID: 34618896

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

74 results

Search Page